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Abstract
Background: During the previous century Norway had a high incidence of tuberculosis, but no molecular epidemiological
studies could be performed and these previously epidemic strains have been disappearing during the last decades.
Currently, tuberculosis among native Norwegians is in the elimination phase, and it is still not known what type of M.
tuberculosis was so efficiently controlled during the second half of the 20th century. However, many elderly Norwegian-born
people still develop TB that cannot be clustered to imported or recently transmitted strains of M. tuberculosis. Thus, the
majority of these cases are results of reactivation of disease that was transmitted many decades ago.
Methodology/Principal Findings: A total of 213 strains of M. tuberculosis isolated during 1998–2005, from patients born in
Norway before 1950 were genotyped in the current study. The findings demonstrated a highly homogenous M. tuberculosis
population among the patients. A total of 40% belonged to the T-family, were 35% were assigned to T1 sub- family (T2=0,
93%, T3=1, 4% and T4=2, 3%). As many as 35% of the isolates belonged to the Haarlem family, were 15% were assigned to
Haarlem1 and 19% to Haarlem3. The remaining 25% belonged to 15 different other families. The RFLP-patterns indicated
that the isolates were not a result of recent transmission, but rather represented well established strains that apparently
dominated in Norway many decades ago.
Conclusions/Significance: The T 1, Haarlem 1, and Haarlem 3 families of M. tuberculosis were abundant among patients
born in Norway before 1950. The M. tuberculosis cases represented reactivated disease that had been acquired before 1994
and were likely to have been latent for several decades. Thus, the current study indicated that the T 1, Haarlem 1, and
Haarlem 3 families may have been common in Norway, when tuberculosis represented a serious public health threat during
the first half of the 20th century.
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Introduction
Studying changes in the population structure of M. tuberculosis is
important to help understand the adaptation infectious agents
undergo to control measures. Although it remains to be proven
conclusively, it is conceivable that control measures such as the
Mycobacterium bovis BCG vaccine and antituberculosis drugs have
facilitated a selection of strains which are better adapted to resist
such measures [1]. If so, it is important to test the efficacy of new
candidate vaccines and drugs against such successful genotypes. It
is equally important to identify what genotypes were controlled by
those measures employed during the previous century. Preclinical
experiments have clearly demonstrated that M. tuberculosis isolates
exhibit different levels of virulence and induce various immune
responses in animal models [2–4]. So far however, changes in the
population structure of M. tuberculosis are largely based on studies
of currently abundant strains. Few collections of isolates from the
20
th century are available but they may still be found in elderly
patients suffering from reactivated disease.
The incidence of tuberculosis in Norway was among the highest
in the world less than a century ago and currently it represents one
of the lowest in the world. Tuberculosis is close to elimination
among native people in Norway [5], yet we do not know what
strains of M. tuberculosis were so efficiently controlled. The elderly
Norwegian-born patients that develop reactivated tuberculosis
today represent the last survivors of the disappearing Norwegian
tuberculosis epidemic. The strains isolated from these patients
represent a unique chance to describe a part of the M. tuberculosis
population that was a major public health threat well into the
1960s. Such studies may represent important arguments in the
common theories that given families of M. tuberculosis are currently
emerging in various parts of the world.
Materials and Methods
Ethics Statement
At the Norwegian Institute of Public Health, all M. tuberculosis
strains are routinely collected for disease surveillance. The current
study is descriptive of a bacterial collection and bacterial genotypes
could only be combined with the sex, year of birth, and country of
birth for the patients from which the strains were isolated. Ethical
approval was therefore not required. Also, the Norwegian Act
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no/all/hl-19940805-055.html#7-9) obliges the Norwegian Insti-
tute of Public Health to monitor the mycobacterial population
within the country on a regular basis. For these reasons, consent
was not obtained from the patients to analyze the bacterial samples
for this research project.
The study population comprised patients from whom at least
one sample positive for M. tuberculosis by culture was collected
during 1998–2005. The patients were born in Norway before 1950
and the M. tuberculosis isolates from these patients carried an
IS6110 RFLP pattern that had previously not been observed in
Norway. The IS6110 RFLP database included the patterns of all
culture positive tuberculosis cases diagnosed in Norway since
1994. It was therefore considered unlikely that the patients had
been recently infected within the country by imported M.
tuberculosis strains. The species identification of the isolates was
based on a 16S-rDNA hybridization technique (AccuProbe;
GenProbe Inc., San Diego, USA) and standard microbiological
tests (nitrate reduction and niacin accumulation tests).
A total of 1903 strains were analyzed by IS6110 RFLP during
1998–2007. Of these were 418 isolated from native Norwegians.
Strains carrying an RFLP pattern that had first been isolated in a
person born after 1950 or in another country were excluded for
the study. A final 213 strains were identified as likely cases of
reactivated M. tuberculosis infection and analyzed by spoligotyping.
Only 21 of the included strains carried an RFLP pattern that had
also been observed in isolates from other patients. However, the 21
included outbreak strains all represented cases where the index
patient was born in Norway before 1950.
The spoligotyping methodology is described elsewhere [6]. The
spoligopatterns were compared by visual examination and
computer assisted analyses by use of the BioNumerics, version
5.1 software (Applied Maths, Kortrijk, Belgium). The obtained
spoligopatterns were assigned to families and subfamilies based on
the SpolDB4 database [7] and the ‘Spotclust’ algorithm [8].
Results
All included patients were born in Norway between 1910 and
1950, at a time when the incidence of pulmonary tuberculosis in
Norway sunk from 400/100.000 to 100/100.000. A total of 10%
of the included patients were born before 1914, 20% were born
during 1915–1919, 17% were born during 1920–1924, 23% were
born during 1925–1929, 12% were born during 1930–1934, 5%
were born during 1935–1939, 5% were born during 1940–1944,
and 8% were born during 1945–1950 (figure 1). A total of 128
men (60%) and 85 (40%) women were included.
The isolates demonstrated a highly homogenous population with
little genetic variation although identical isolates were not included.
The T- (40%) and Haarlem- (35%) families dominated among the
isolates and only 25% belonged to other families (table 1).
Among the strains assigned to the Haarlem 1 sub-family, 24
carried identical spoligopatterns. All these were separated by
IS6110 RFLP yet the identical spoligopattern supported the
hypothesis that the strains had a common evolutionary and
epidemiological background (Table 1, Fig 2). Figures 3 and 4
demonstrates the genetic similarity among these strains obtained
by IS6110 RFLP analysis. All isolates are within a 70% homology
and all single isolates demonstrate at least one very closely related
strain although no clustering could be observed according to age,
sex or current residence (data not shown). The IS6110 RFLP
dendrograms of the two dominant lineages were considered
comparable to those of well established epidemics and represent
local evolution rather that recent import and transmission.
A total of 23 among 41 (56%) isolates assigned to the Haarlem 3
family had identical spoligopatterns (Fig 2) and 21 of them were
separated by IS6110-RFLP although their genetic similarity was
above 70%. The T1 family demonstrated similar diversities as that
Figure 1. Incidence of tuberculosis and distribution of birth-
year of patients from where the current M. tuberculosis strains
originated. The incidence of pulmonary tuberculosis in Norway 1910–
1990 (dotted line) is presented in a logarithmic scale (left axis). The
distribution of year of birth of the patients from whom the current M.
tuberculosis population had been isolated during 1998–2008 (solid line)
is given in percent (right axis).
doi:10.1371/journal.pone.0008373.g001
Table 1. M. tuberculosis families identified in cases of
reactivated disease among patients born in Norway before
1950.







Haarlem 1 33 15,4%
Haarlem 3 41 19,1%
Other families (25%) Beijing family 5 2,3%
EAI1 family 3 1,4%
EAI2 family 5 2,3%
EAI4 family 2 0,93%
33 family 3 1,4%
34 family 3 1,4%
35 family 1 0,46%
36 family 5 2,3%
X3 family 3 1,4%
LAM1 family 5 2,3%
LAM6 family 1 0,46%
LAM8 family 4 1,8%
LAM9 family 12 5,6%
CAS family 1 0,46%
S family 1 0,46%
doi:10.1371/journal.pone.0008373.t001
Historic TB in Norway
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the 214 isolates analyzed in this study, were 75 identified as T1
family by spoligotyping and 51.9% of the isolates within this family
had identical spoligopattern. The IS6110 RFLP analysis results
differentiated the isolates and demonstrated a similarity above
65%.
Figure 2. The diversity of spoligopatterns in M. tuberculosis isolates from patients born in Norway between 1910 and 1950. Percent
homology, spoligopatterns, family assignment, and number of isolates carrying each pattern, among M. tuberculosis strains isolated from Norwegian-
born patients during 1998–2008. All cases were considered reactivation of remote infection. Abbreviations: EAI: East African Indian-family, LAM: Latin
American Mediterranean-family, T: T-family, H: Haarlem-family, S: S-family, X: X-family, CAS: Central Asian-family [7].
doi:10.1371/journal.pone.0008373.g002
Historic TB in Norway
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The M. tuberculosis strains included in the current study were
isolated in patients born in Norway between 1910 and 1950.
Norway is a relatively small country with a currently low incidence
of M. tuberculosis infections. Among 300–400 notified cases each
year, 200–300 are culture positive. Since 1994, all cultures of M.
tuberculosis are analyzed with IS6110 RFLP at the Norwegian
Institute of Public Health [5]. The DNA patterns of the included
strains had not previously been observed in the IS6110 RFLP
database, and where therefore unlikely to have been recently
transmitted in Norway after 1993. Since travel-records of the
patients were incomplete, it could not be ruled out that some of the
patients were recently infected outside Norway. However, the low
rate of diversity in the M. tuberculosis population strongly indicated
that the majority of these isolates had a common epidemiological
Figure 3. Diversity and RFLP patterns observed among M. tuberculosis strains, sex, and year of birth of patients from whom these
were isolated. Genetic diversity and IS6110- RFLP patterns of the isolates assigned to the T- family from patients born in Norway 1910-1950.
doi:10.1371/journal.pone.0008373.g003
Historic TB in Norway
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losis epidemic that plagued Norway prior to the 1960s [9]. During
the first half of the 20
th century, Norway experienced large
regional differences of tuberculosis infection and mortality. The
northern part of the country had the highest infection rates and
mortality due to tuberculosis [9]. Such differences were not
observed in the current analysis, as the genotypes of M. tuberculosis
were evenly distributed throughout the country. Internal migra-
tion within Norway is low and migration between different parts of
the country remains stable at 5–7%. The majority of internal
migrants are in the age group 20–34 years (statistics Norway:
www.ssb.no). Thus the patients of the current analysis represented
a group that rarely migrated within Norway.
Spoligopatterns of M. tuberculosis evolve through the successive
loss of DNA spacers which separate the short direct repeat
sequences in the M. tuberculosis genome. Deletions of such spacers
Figure 4. Diversity and RFLP patterns observed among M. tuberculosis strains, sex, and year of birth of patients from whom these
were isolated. Genetic diversity and IS6110- RFLP patterns of the isolates assigned to the Haarlem- family from patients born in Norway 1910–1950.
doi:10.1371/journal.pone.0008373.g004
Historic TB in Norway
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develop in unrelated strains as a result of convergent evolution
[10,11]. The method has however been in use for more than a
decade and tens of thousands of strains have been typed to
describe the various lineages of M. tuberculosis that dominate in
various parts of the world. These studies have resulted in the
detection and description of emerging strains that may represent
vaccine escape variants or strains that acquire drug resistance
more readily than others, or harbor other characteristics that
render them especially successful [12,13].
When tubercle bacilli first enter human bodies they usually
remain through the rest of their hosts’ lives and are capable of
causing clinical disease any time. Tuberculosis has thus long been
prevalent among elderly people. In the current study the Haarlem
and T lineages as defined by spoligotyping [7], dominated among
Norwegian-born patients diagnosed with tuberculosis that were
considered not recently transmitted in Norway. The T1 and
Haarlem 3 sublineages were the most commonly observed
spoligopatterns. The Haarlem 3 pattern was also observed in
18
th century Hungarian bodies [14], demonstrating that this
particular lineage had been present in Europe for centuries. It has
been demonstrated that M. tuberculosis strains isolated in Denmark
during the 1960s were carried as latent infections during 4
decades, without changing their IS6110 RFLP patterns [15]. The
Danish strains also carried IS6110 RFLP patterns of high
homology to those included in the current study. The Danish
comparison between historical and recently isolated strains of M.
tuberculosis yielded convincing evidence that reactivation occurred
many decades after initial infection [15]. In Hong Kong, old age
home residents have a high prevalence of latent tuberculosis that is
responsible for the high rate of active disease due to reactivation.
There it was concluded that elderly represents a large reservoir of
tuberculosis infection [16,17]. For these reasons, we believe that
the Norwegian century-old tuberculosis epidemic, which is
currently in the elimination phase, was partly caused by M.
tuberculosis isolates within the T and Haarlem families.
Numerous projects have identified M. tuberculosis strains that
may represent emerging types and that harbor higher abilities to
resist anti-TB drugs and/or BCG vaccination [18–22]. Vaccines
that target only a proportion of a specific pathogen population
may exert selective pressures that can promote vaccine escape
variants or even promote changes in microbial virulence [23,24].
The efficacy of new tuberculosis vaccines and drugs, risk-factors
for infections and other epidemiological aspects need to be
correlated to emerging strains [23]. However, the strains that are
identified as emerging are not simply those with the largest
number of cases [20].
The lineages of M. tuberculosis that dominated among elderly
patients diagnosed with assumed reactivated tuberculosis during
1998–2008, probably represented strains that are about to be
eliminated after more than a century of tuberculosis control efforts
in Norway [9]. It is not known how long each patient had been
latently infected. However, the transmission rate of M. tuberculosis
in Norway is currently very low [5], and the close genetic
relatedness between the isolates indicated that they were acquired
from a local epidemic in the past.
Strains of M. tuberculosis that were transmitted in the past and
developed disease after long periods of latent infection, need not be
a representative part of the bacterial population that circulated
previously. Since various strains of M. tuberculosis harbor different
levels of pathogenicity, levels of drug resistance, or other
phenotypic characteristics [21,25], it is possible that specific
strains that demonstrated short latency-periods, or high mortality-
rates in patients have already been eliminated from the
Norwegian-born population. Such strain related differences have
been recently demonstrated in other studies [26,26] However, we
believe that the Haarlem 1, Haarlem 3 and T 1 families represent
parts of the TB epidemic that scourged Norway during the first
half of the 20th century. These strains are still abundant in many
parts of the world [7], but should not be considered emerging as
they represent strains that circulated in a high-incidence setting
several decades ago.
A general goal in the control of infectious diseases has been to
classify isolates into distinct epidemiological, immunological or
virulent types. In the case of M. tuberculosis, one of the outcomes of
genetic typing has been the identification of particularly aggressive
or successful strains. The T and Haarlem strains are usually not
considered among such successful strains, although they remain
highly endemic in most parts of the world [7]. They have been
assigned to the ‘‘modern M. tuberculosis strains’’ [23,27,28], and
appear to have been successfully controlled in Norway through a
rigorous control program described elsewhere [5]. Clear defini-
tions of the ‘‘T’’ families (modern tuberculosis strains) are still
absent and more than 600 unclassified spoligopatterns have been
found among these strains [7]. The T and Haarlem strains that
were abundant in the old-age Norwegian population studied in the
current paper has been repeatedly isolated in the countries of the
former Soviet Union [7,29]. They are generally not associated
with drug resistance on major outbreaks, thus epidemiologically
the current isolates share these phenotypic traits.
The T 1, Haarlem 1, and Haarlem 3 families of M. tuberculosis
were abundant among patients born in Norway between 1910 and
1950. The M. tuberculosis cases represented reactivated disease that
had been acquired before 1994 and were likely to have been latent
for several decades. Thus, the current study indicated that the T 1,
Haarlem 1, and Haarlem 3 families were common in Norway,
when tuberculosis represented a serious public health threat
during the first half of the 20
th century.
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